Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Carcinoma, Renal Cell 2 Brain Neoplasms 2 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neuroendocrine Tumors (pNET) 1 Oropharyngeal Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1 Anus Neoplasms 1 Anatomic Stage II Breast Cancer AJCC v8 1 Anal Canal Carcinoma 1

Interventions

pembrolizumab 9 Cetuximab 5 Surveys and Questionnaires 4 Cisplatin 4 dostarlimab 2 abemaciclib 2 Standard of Care 2 Docetaxel 2 Carboplatin 2 130-nm albumin-bound paclitaxel 2 ulixertinib 1 trastuzumab deruxtecan 1 toripalimab 1 tislelizumab 1 tipifarnib 1 ribociclib 1 repotrectinib 1 patritumab deruxtecan 1 palbociclib 1 olaparib 1 nimotuzumab 1 monalizumab 1 ibrutinib 1 fludarabine 1 exemestane 1 entrectinib 1 ebselen 1 durvalumab 1 disitamab vedotin 1 avelumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Head and Neck Neoplasms × Watchful Waiting × 30 days × Clear all

NCT06998342 2026-05-26

MOHSAHRTSS

University of Vermont Medical Center

Phase 2 Recruiting

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡